AASLD/EASL NAFLD Nomenclature Consensus Conference

5 (3 votes)

Recordings from the AASLD/EASL NAFLD Nomenclature Consensus Conference can be accessed here. The conference took place July 8-9, 2022 in Chicago, IL and virtually.

Key:

Complete
Failed
Available
Locked
Friday, July 8, 2022
Pre-Meeting
Recorded 09/30/2022
Recorded 09/30/2022 Presentation: The PBC Story - How We Did It
You must register to access.
Session I (Part 1)
Open to view video.
Open to view video. This recording includes the following presentations: - Welcoming and Opening Remarks - Stage Setting - Achieving Consensus in a Divided World - Overview of the Methodology - Patient Considerations - Why a Nomenclature Change Now?
You must register to access.
Session I (Part 2)
Open to view video.
Open to view video. This recording includes the following presentation: - Breakout Group Table Discussions
You must register to access.
Session II
Open to view video.
Open to view video. This recording includes the following presentations: - Topics Requiring Further Consideration - Phenotyping of a Heterogeneous Disease - Definition of a Metabolic Dysfunction - Critical Nomenclature Considerations in Pediatrics - Evaluating the Contributions of Alcohol to Liver Injury in Setting of Fatty Liver - Impact of Nomenclature Change on Biomarker Qualifications
You must register to access.
Session III
Open to view video.
Open to view video. This recording includes Table Discussions on the following Breakout Groups: - Patient Stigma - Impact on Clinical Trials - Impact on Biomarker Qualification - Critical Nomenclature Considerations in Pediatrics - Phenotyping and Disease Heterogeneity - Role and Management of Alcohol in the Context of NAFLD
You must register to access.
Session IV (Part 1)
Open to view video.
Open to view video. This recording includes the Key Criteria to Achieve Consensus on Nomenclature Change presentation.
You must register to access.
Session IV (Part 2)
Open to view video.
Open to view video. This recording includes presentations from the Nomenclatures Under Consideration: Benefits and Limitations Panel Discussion: - Nutrition Associated Fatty Liver Disease - Fatty/Steatotic Liver Disease - Metabolic-Associated Fatty Liver Disease - NAFLD
You must register to access.
Saturday, July 9, 2022
Session V (Part 1)
Open to view video.
Open to view video. This recording includes the Morning Reflections presentation.
You must register to access.
Session V (Part 2)
Open to view video.
Open to view video. This recording includes the following presentations: - Progressing our Thinking Forward - Industry Round Table - Pulling It All Together - A Report Back and Next Steps
You must register to access.